NEW YORK, May 25 (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson’s Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.
The case of Bertila Boyd-Bostic, who died of a rare form of cancer in 2017 at the age of 30, is the latest in a series of trials in the United States that center around allegations that the company’s talc-based powder contained asbestos.
J&J said that its widely-used baby powder never contained asbestos or causes cancer and denies the accusations, citing decades of testing by independent laboratories and scientists.
Asbestos is a known carcinogen linked to mesothelioma, the type of cancer Boyd-Bostic had been diagnosed with at the age of 29.
After two weeks of trial, the jury in the Darlington County Court of Common Pleas said it could not decide whether J&J was responsible for the disease. Under South Carolina law, a jury has to make a unanimous decision.
J&J did not immediately respond to a request for comment.
Christopher Swett, a lawyer for the family of Boyd-Bostic, said in a statement that the plaintiffs would retry the case at the earliest opportunity.
“We continue to believe that the daily use of baby powder on Bertila from birth led to her death,” Swett said.
The case also named as a defendant the U.S. unit of talc supplier Imerys SA, as well as a local unit of Rite Aid, one of the largest U.S. drugstore chains, which allegedly sold the baby powder used by the woman.
Imerys Talc America and Rite Aid did not immediately respond to a request for comment.
J&J is battling some 9,000 cases claiming its talc products cause ovarian cancer, but litigants have recently focused on claims based on alleged asbestos contamination.
A California jury on Thursday awarded $25.7 million in damages to a woman and her husband over allegations that the company’s baby powder had caused her mesothelioma.
A New Jersey court jury in April ordered J&J and Imerys Talc America to pay $117 million to a man who alleged he developed mesothelioma due to asbestos exposure from talc-based products.
The company won the only other asbestos-related trial in November, when a Los Angeles Superior Court jury ruled in its favor.
Reporting by Tina Bellon, Editing by Rosalba O'Brien